LTRN
Price
$3.46
Change
-$0.14 (-3.89%)
Updated
Jul 13 closing price
Capitalization
44.15M
30 days until earnings call
Intraday BUY SELL Signals
XOMAO
Price
$25.00
Change
+$0.02 (+0.08%)
Updated
Jul 13 closing price
Capitalization
N/A
Intraday BUY SELL Signals
Interact to see
Advertisement

LTRN vs XOMAO

LTRN vs XOMAO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
LTRN vs. XOMAO commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LTRN is a Hold and XOMAO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (LTRN: $3.60 vs. XOMAO: $25.00)
Brand notoriety: LTRN and XOMAO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LTRN: 39% vs. XOMAO: 41%
Market capitalization -- LTRN: $44.15M vs. XOMAO: $0
LTRN [@Biotechnology] is valued at $44.15M. XOMAO’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LTRN’s FA Score shows that 0 FA rating(s) are green whileXOMAO’s FA Score has 1 green FA rating(s).

  • LTRN’s FA Score: 0 green, 5 red.
  • XOMAO’s FA Score: 1 green, 4 red.
According to our system of comparison, XOMAO is a better buy in the long-term than LTRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LTRN’s TA Score shows that 6 TA indicator(s) are bullish while XOMAO’s TA Score has 5 bullish TA indicator(s).

  • LTRN’s TA Score: 6 bullish, 4 bearish.
  • XOMAO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, LTRN is a better buy in the short-term than XOMAO.

Price Growth

LTRN (@Biotechnology) experienced а -9.32% price change this week, while XOMAO (@Biotechnology) price change was +0.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.13%. For the same industry, the average monthly price growth was +7.30%, and the average quarterly price growth was +1806.57%.

Reported Earning Dates

LTRN is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (-3.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LTRN YTD gains are higher at: 14.191 vs. XOMAO (4.216). XOMAO has higher annual earnings (EBITDA): 50.2M vs. LTRN (-16.59M). XOMAO has more cash in the bank: 93.3M vs. LTRN (6.32M). LTRN has less debt than XOMAO: LTRN (59.1K) vs XOMAO (125M). XOMAO has higher revenues than LTRN: XOMAO (7.65M) vs LTRN (0).
LTRNXOMAOLTRN / XOMAO
Capitalization44.1MN/A-
EBITDA-16.59M50.2M-33%
Gain YTD14.1914.216337%
P/E RatioN/AN/A-
Revenue07.65M-
Total Cash6.32M93.3M7%
Total Debt59.1K125M0%
FUNDAMENTALS RATINGS
LTRN: Fundamental Ratings
LTRN
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LTRNXOMAO
RSI
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
12%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
9%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
17%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
18%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
15%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 5 days ago
19%
Declines
ODDS (%)
Bearish Trend 12 days ago
85%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
5%
Aroon
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
17%
View a ticker or compare two or three
Interact to see
Advertisement
LTRN
Daily Signal:
Gain/Loss:
XOMAO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIEYX17.16N/A
N/A
Saratoga International Equity A
ALCZX23.02N/A
N/A
Alger International Opportunities Z
CDHIX45.01N/A
N/A
Calvert International Responsible Idx I
VQSRX24.72N/A
N/A
Virtus KAR Small-Cap Value R6
JFNAX85.98-0.66
-0.76%
Janus Henderson Global Life Sciences A

LTRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with ALZN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
-3.89%
ALZN - LTRN
41%
Loosely correlated
-2.52%
PDSB - LTRN
38%
Loosely correlated
-3.71%
AXON - LTRN
36%
Loosely correlated
-3.32%
WHWK - LTRN
34%
Loosely correlated
-3.27%
RCKT - LTRN
31%
Poorly correlated
-4.86%
More

XOMAO and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMAO has been closely correlated with AMLX. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if XOMAO jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMAO
1D Price
Change %
XOMAO100%
+0.08%
AMLX - XOMAO
68%
Closely correlated
-2.03%
NRSN - XOMAO
26%
Poorly correlated
+0.21%
ATAI - XOMAO
24%
Poorly correlated
-3.87%
LTRN - XOMAO
23%
Poorly correlated
-3.89%
BOLD - XOMAO
23%
Poorly correlated
+1.24%
More